Indication
Atypical Hyperplasia
3 clinical trials
3 products
2 drugs
Clinical trial
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium (WE-FiERCE)Status: Not yet recruiting, Estimated PCD: 2028-09-01
Product
MounjaroProduct
MirenaClinical trial
Randomized Placebo-controlled Phase III Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upStatus: Active (not recruiting), Estimated PCD: 2022-12-31
Drug
TamoxifenDrug
placeboClinical trial
Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial CancerStatus: Active (not recruiting), Estimated PCD: 2023-12-13
Product
Exemestane